Updated:23 Feb 2017 03:31:00 PM(IST)
|Bse Corporate Announcements||Back|
|Outcome of Allotment Committee meeting of Sun Pharmaceutical Industries|
|Sun Pharmaceutical Industries announced that the Allotment Committee of the Board of Directors has approved the following at their meeting held on 10 April 2015 pursuant to merger of erstwhile Ranbaxy into the Company:
1. Allotment of 334,956,764 (Thirty Three Crore Forty Nine Lakh Fifty Six Thousand Seven Hundred and Sixty Four) equity shares of Re. 1 each to the shareholders of erstwhile Ranbaxy in the ratio of 8 (eight) equity shares of Re. 1 each of the Company for every 10 (ten) equity shares of Rs. 5 each of erstwhile Ranbaxy held. After allotment, the total number of issued and paid up equity shares of the Company has aggregated to 2,406,120,674 of Re. 1 each.
2. Allotment of 5,000 Secured Rated Redeemable 9.20% Non-Convertible Debentures of the Face Value of Rs. 10,00,000/- each to the NCD holders of erstwhile Ranbaxy in the ratio of 1 (One) NCD of Rs. 10 lac each of the Company for every 1 (One) NCD of Rs.10 lac each held in erstwhile Ranbaxy. After allotment the total number of NCDs of the Company is 5,000 Secured Rated Redeemable 9.20% Non-Convertible Debentures of the Face Value of Rs. 10,00,000/- each.